Repository logo
 

An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression.

Published version
Peer-reviewed

Type

Article

Change log

Authors

Palazon, Asis 
Tyrakis, Petros A 
Macias, David 
Veliça, Pedro 
Rundqvist, Helene 

Abstract

Cytotoxic T cells infiltrating tumors are thought to utilize HIF transcription factors during adaptation to the hypoxic tumor microenvironment. Deletion analyses of the two key HIF isoforms found that HIF-1α, but not HIF-2α, was essential for the effector state in CD8+ T cells. Furthermore, loss of HIF-1α in CD8+ T cells reduced tumor infiltration and tumor cell killing, and altered tumor vascularization. Deletion of VEGF-A, an HIF target gene, in CD8+ T cells accelerated tumorigenesis while also altering vascularization. Analyses of human breast cancer showed inverse correlations between VEGF-A expression and CD8+ T cell infiltration, and a link between T cell infiltration and vascularization. These data demonstrate that the HIF-1α/VEGF-A axis is an essential aspect of tumor immunity.

Description

Keywords

HIF transcription factors, VEGF, angiogenesis, cytotoxic T cells, hypoxia, immunotherapy, Animals, Breast Neoplasms, CD8-Positive T-Lymphocytes, Cell Line, Tumor, Cells, Cultured, Disease Progression, Female, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Humans, Hypoxia-Inducible Factor 1, alpha Subunit, Mice, Inbred C57BL, Mice, Knockout, Neoplasms, Experimental, Neovascularization, Pathologic, T-Lymphocytes, Cytotoxic, Vascular Endothelial Growth Factor A

Journal Title

Cancer Cell

Conference Name

Journal ISSN

1535-6108
1878-3686

Volume Title

32

Publisher

Elsevier BV
Sponsorship
Wellcome Trust (092738/Z/10/Z)
European Commission (331756)
National Cancer Institute (R01CA153983)
Wellcome Trust (214283/Z/18/Z)
National Institute of Allergy and Infectious Diseases (R01AI096852)